Oncocyte Corp
OCX
Revenue
1.49M
▲1.37M▲1192.17%
3 Months ChangeAssets
35.08M
▼-35.14M▼-50.04%
3 Months ChangeLiabilities
47.36M
▼-13.15M▼-21.73%
3 Months ChangeFree Cash Flow
-3.85M
▲10.98M▲74.03%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-15
Form 8-K
ID: 0001493152-24-041133
2024-10-03
Form 8-K
ID: 0001493152-24-039269
2024-08-09
Form 8-K
ID: 0001493152-24-030865
2024-08-08
Form 10-Q
ID: 0001493152-24-030793
2024-08-08
Form 8-K
ID: 0001493152-24-030771
2024-07-12
Form 8-K
ID: 0001493152-24-027086
2024-07-05
Form 8-K
ID: 0001493152-24-026335
2024-06-17
Form 8-K
ID: 0001493152-24-024108
2024-05-31
Form 8-K
ID: 0001493152-24-022193
2024-05-23
Form 8-K
ID: 0001493152-24-021144